MedTrace Logo

Highly Active Antiretroviral Therapy (HAART) Adherence Interventions

NCT00273780 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2012-08-27

No results posted yet for this study

Summary

This study proposes a 4-armed factorial randomized clinical trial in Nairobi, Kenya to determine the effect of cognitive and behavioral interventions on HAART adherence.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Adherence counseling

Three adherence counseling sessions will be given to participants in the trial. Two sessions will occur prior to initiation of antiretroviral medications and one session will be given one month after drug administration.

DEVICE

Alarm device

This pocket alarm device will be set to ring at designated times during the day that the participant should take their antiretroviral medication.

Sponsors & Collaborators

Principal Investigators

  • Michael H Chung, MD, MPH · University of Washington

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00273780 on ClinicalTrials.gov